Your browser doesn't support javascript.
loading
Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer.
Deutsch, E; Le Péchoux, C; Faivre, L; Rivera, S; Tao, Y; Pignon, J-P; Angokai, M; Bahleda, R; Deandreis, D; Angevin, E; Hennequin, C; Besse, B; Levy, A; Soria, J-C.
Afiliação
  • Deutsch E; Department of Radiation Oncology; Drug Development Department (DITEP), Gustave Roussy, Paris-Sud University, Villejuif; Paris-Sud University, Kremlin-Bicêtre Medical University, DHU TORINO, SIRIC SOCRATES, LABEX LERMIT; INSERM 1030 Molecular Radiotherapy, Cancer research institute, Villejuif. Electr
  • Le Péchoux C; Department of Radiation Oncology; Institut d'Oncologie Thoracique (IOT).
  • Faivre L; Departments of Biostatistics.
  • Rivera S; Department of Radiation Oncology; Drug Development Department (DITEP), Gustave Roussy, Paris-Sud University, Villejuif.
  • Tao Y; Department of Radiation Oncology; Drug Development Department (DITEP), Gustave Roussy, Paris-Sud University, Villejuif.
  • Pignon JP; Departments of Biostatistics.
  • Angokai M; Departments of Biostatistics.
  • Bahleda R; Drug Development Department (DITEP), Gustave Roussy, Paris-Sud University, Villejuif.
  • Deandreis D; Nuclear Medicine, Gustave Roussy, Villejuif.
  • Angevin E; Drug Development Department (DITEP), Gustave Roussy, Paris-Sud University, Villejuif.
  • Hennequin C; Department of Radiation Oncology, Saint Louis Hospital, Paris.
  • Besse B; Institut d'Oncologie Thoracique (IOT); Department of Medicine, Gustave Roussy, Villejuif, France.
  • Levy A; Department of Radiation Oncology; Drug Development Department (DITEP), Gustave Roussy, Paris-Sud University, Villejuif; INSERM 1030 Molecular Radiotherapy, Cancer research institute, Villejuif; Institut d'Oncologie Thoracique (IOT).
  • Soria JC; Drug Development Department (DITEP), Gustave Roussy, Paris-Sud University, Villejuif; Paris-Sud University, Kremlin-Bicêtre Medical University, DHU TORINO, SIRIC SOCRATES, LABEX LERMIT; Institut d'Oncologie Thoracique (IOT).
Ann Oncol ; 26(6): 1223-1229, 2015 Jun.
Article em En | MEDLINE | ID: mdl-25701455
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Radioterapia Conformacional / Inibidores de Proteínas Quinases / Quimiorradioterapia / Everolimo / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Etiology_studies País/Região como assunto: Europa Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Radioterapia Conformacional / Inibidores de Proteínas Quinases / Quimiorradioterapia / Everolimo / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Etiology_studies País/Região como assunto: Europa Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article